Performance of narrow band imaging (NBI) and photodynamic diagnosis (PDD) fluorescence imaging compared to white light cystoscopy (WLC) in detecting non …

GI Russo, TN Sholklapper, A Cocci, G Broggi… - Cancers, 2021 - mdpi.com
Simple Summary Bladder cancer is one of the most common malignancies in the United
States with a majority of patients diagnosed with non-muscle invasive bladder cancer …

Advances in diagnosis and therapy for bladder cancer

X Hu, G Li, S Wu - Cancers, 2022 - mdpi.com
Simple Summary The clinical management of bladder cancer has been developing in the
past decade, including diagnostic tools and treatment options. Both monotherapy and …

[PDF][PDF] EAU guidelines

P Gontero, E Comperat, JD Escrig… - Edn. presented at the …, 2023 - bladdercare.com
1.1 Aim and scope This overview represents the updated European Association of Urology
(EAU) Guidelines for Non-muscleinvasive Bladder Cancer (NMIBC), TaT1 and carcinoma in …

[HTML][HTML] Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?

N Humayun-Zakaria, DG Ward, R Arnold… - Translational …, 2021 - ncbi.nlm.nih.gov
Urothelial bladder cancer is a complex disease displaying a landscape of heterogenous
molecular subtypes, mutation profiles and clinical presentations. Diagnosis and surveillance …

A longitudinal single center analysis of T1HG bladder cancer: an 18 year experience

C Yong, SL Mott, RL Steinberg, VT Packiam… - … Oncology: Seminars and …, 2022 - Elsevier
Objectives To re-evaluate the treatment of T1HG bladder cancer by analyzing our
experience over 18 years. Methods and Materials An IRB-approved, single-institution …

Underutilization of blue light cystoscopy for bladder cancer in the United States

P Lewicki, C Arenas-Gallo, Y Qiu, S Venkat… - European Urology …, 2022 - Elsevier
Blue light cystoscopy (BLC) during transurethral resection of bladder tumor (TURBT) is
guideline-recommended as it improves cancer detection and decreases recurrence of the …

Clinical and economic impact of blue light cystoscopy in the management of NMIBC at US ambulatory surgical centers: what is the site-of-service disparity?

ND Shore, MB Gavaghan - Urologic Oncology: Seminars and Original …, 2023 - Elsevier
Abstract Introduction and Objective Management of non-muscle-invasive bladder cancer
(NMIBC) significantly impacts healthcare resource utilization due to requirements for …

Utility of blue light cystoscopy for post-bacillus Calmette-Guérin bladder cancer recurrence detection: Implications for clinical trial recruitment and study comparisons

MR Chappidi, H Yang, MV Meng… - The Journal of …, 2022 - auajournals.org
Purpose: The utility of blue light cystoscopy (BLC) in patients receiving bacillus Calmette-
Guérin (BCG) during post-treatment cystoscopy is not well understood. Our objective was to …

Macro and microeconomics of blue light cystoscopy with CYSVIEW® in non-muscle invasive bladder cancer

SB Williams, MB Gavaghan, A Fernandez… - … Oncology: Seminars and …, 2022 - Elsevier
Objective To determine the estimated budget impact to practices that incorporate blue light
cystoscopy (BLC) with hexaminolevulinate HCl (HAL) for the surveillance of non-muscle …

Surveillance of non‐muscle‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis

R Sari Motlagh, A Ghoreifi, T Yanagisawa… - BJU …, 2024 - Wiley Online Library
Objective To compare the value of flexible blue‐light cystoscopy (BLC) vs flexible white‐light
cystoscopy (WLC) in the surveillance setting of non‐muscle‐invasive bladder cancer …